These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34258746)

  • 1. Safe-in-Man Broad Spectrum Antiviral Agents.
    Yao R; Ianevski A; Kainov D
    Adv Exp Med Biol; 2021; 1322():313-337. PubMed ID: 34258746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and development of safe-in-man broad-spectrum antiviral agents.
    Andersen PI; Ianevski A; Lysvand H; Vitkauskiene A; Oksenych V; Bjørås M; Telling K; Lutsar I; Dumpis U; Irie Y; Tenson T; Kantele A; Kainov DE
    Int J Infect Dis; 2020 Apr; 93():268-276. PubMed ID: 32081774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing drugs targeting epidemic viruses.
    Namasivayam V; Palaniappan S; Vanangamudi M
    Drug Discov Today; 2022 Jul; 27(7):1874-1894. PubMed ID: 35427764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
    Mercorelli B; Palù G; Loregian A
    Trends Microbiol; 2018 Oct; 26(10):865-876. PubMed ID: 29759926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of antivirals: broad-spectrum inhibitors.
    Debing Y; Neyts J; Delang L
    Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel activities of safe-in-human broad-spectrum antiviral agents.
    Ianevski A; Zusinaite E; Kuivanen S; Strand M; Lysvand H; Teppor M; Kakkola L; Paavilainen H; Laajala M; Kallio-Kokko H; Valkonen M; Kantele A; Telling K; Lutsar I; Letjuka P; Metelitsa N; Oksenych V; Bjørås M; Nordbø SA; Dumpis U; Vitkauskiene A; Öhrmalm C; Bondeson K; Bergqvist A; Aittokallio T; Cox RJ; Evander M; Hukkanen V; Marjomaki V; Julkunen I; Vapalahti O; Tenson T; Merits A; Kainov D
    Antiviral Res; 2018 Jun; 154():174-182. PubMed ID: 29698664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral activity of cationic amphiphilic drugs.
    Salata C; Calistri A; Parolin C; Baritussio A; Palù G
    Expert Rev Anti Infect Ther; 2017 May; 15(5):483-492. PubMed ID: 28286997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs.
    Schor S; Einav S
    DNA Cell Biol; 2018 Feb; 37(2):63-69. PubMed ID: 29148875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broad-spectrum antivirals against viral fusion.
    Vigant F; Santos NC; Lee B
    Nat Rev Microbiol; 2015 Jul; 13(7):426-37. PubMed ID: 26075364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad-spectrum Respiratory Virus Entry Inhibitors.
    Zhao H; Yuen KY
    Adv Exp Med Biol; 2022; 1366():137-153. PubMed ID: 35412139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug repurposing for new, efficient, broad spectrum antivirals.
    García-Serradilla M; Risco C; Pacheco B
    Virus Res; 2019 Apr; 264():22-31. PubMed ID: 30794895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention strategies for emerging viruses: use of antivirals.
    Debing Y; Jochmans D; Neyts J
    Curr Opin Virol; 2013 Apr; 3(2):217-24. PubMed ID: 23562753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomolecular Condensates as Novel Antiviral Targets.
    Martin EW; Iserman C; Olety B; Mitrea DM; Klein IA
    J Mol Biol; 2024 Feb; 436(4):168380. PubMed ID: 38061626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinase Inhibitors as Underexplored Antiviral Agents.
    García-Cárceles J; Caballero E; Gil C; Martínez A
    J Med Chem; 2022 Jan; 65(2):935-954. PubMed ID: 33970631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases.
    Hajjo R; Sabbah DA; Abusara OH; Kharmah R; Bardaweel S
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses.
    Komarasamy TV; Adnan NAA; James W; Balasubramaniam VR
    PLoS Negl Trop Dis; 2022 Apr; 16(4):e0010291. PubMed ID: 35482672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Broad-Spectrum Antiviral Agents-Inspiration from Immunomodulatory Natural Products.
    Zhang M; Zhong J; Xiong Y; Song X; Li C; He Z
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34203182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling the Future Pandemics: Broad-Spectrum Antiviral Agents (BSAAs) Based on A-Type Proanthocyanidins.
    Maffei ME; Salata C; Gribaudo G
    Molecules; 2022 Nov; 27(23):. PubMed ID: 36500445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the activity spectrum of antiviral agents.
    Ianevski A; Andersen PI; Merits A; Bjørås M; Kainov D
    Drug Discov Today; 2019 May; 24(5):1224-1228. PubMed ID: 30980905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.